Department of Neurology, NYU Langone Health, New York, NY, USA.
Department of Neurology, NYU Langone Health, New York, NY, USA.
Parkinsonism Relat Disord. 2018 Sep;54:40-45. doi: 10.1016/j.parkreldis.2018.04.008. Epub 2018 Apr 4.
Psychotic symptoms are underdiagnosed in Parkinson's disease (PD), and there is a need for a comprehensive PD psychosis rating scale.
Cross-sectional analysis of 199 consecutive PD outpatients. After a routine clinical visit that included the Unified Parkinson's Disease Rating Scale (UPDRS) and Non-Motor Symptoms Questionnaire (NMS-Quest), subjects completed the enhanced Scale for the Assessment of Positive Symptoms in PD (eSAPS-PD), a structured clinical interview that included the standard SAPS-PD with additional prompts for delusions and olfactory, gustatory, and minor hallucinations. Based on the combined results of these assessments, subjects were categorized as having major psychotic symptoms (hallucinations or delusions; PDP-major), isolated minor psychotic symptoms (passage hallucinations, presence hallucinations, or illusions; PDP-minor), or no psychotic symptoms (PD-controls).
We identified 58 subjects (29%) with psychotic symptoms, including 28 (14%) with major psychotic symptoms and 30 (15%) with isolated minor psychotic symptoms. Hallucinations were present in 56 subjects (28%); most commonly visual (24%, of which 21% were minor only), followed by olfactory (6%), tactile (4%), auditory (2%), and gustatory (1%). The eSAPS-PD detected psychotic symptoms in more subjects (n = 55, 28%) than all other assessments combined (clinical visit, UPDRS part 1, and NMS-Quest) (n = 22, 11%). Compared with PD-controls, PDP-minor subjects had a higher burden of other non-motor symptoms on the Non-Motor Symptoms Scale (37 [27-51] vs. 18 [9-36], p < 0.001) and lower quality of life scores on the PD Quality of Life Questionnaire (138 [125-151] vs. 149 [137-165], p = 0.01).
The eSAPS-PD can markedly improve detection of psychotic symptoms in PD.
在帕金森病(PD)中,精神病症状被漏诊的情况较为常见,因此需要一种全面的 PD 精神病评定量表。
对 199 例连续的 PD 门诊患者进行横断面分析。在进行常规临床访视后(包括统一帕金森病评定量表(UPDRS)和非运动症状问卷(NMS-Quest)),患者完成增强型 PD 阳性症状评定量表(eSAPS-PD),这是一种结构化的临床访谈,包括标准 SAPS-PD 以及针对妄想和嗅觉、味觉和轻度幻觉的附加提示。根据这些评估的综合结果,患者被归类为存在主要精神病症状(幻觉或妄想;PDP-主要)、孤立的轻度精神病症状(一过性幻觉、存在性幻觉或错觉;PDP-轻度)或没有精神病症状(PD-对照)。
我们发现 58 例(29%)患者存在精神病症状,其中 28 例(14%)存在主要精神病症状,30 例(15%)存在孤立的轻度精神病症状。56 例(28%)患者存在幻觉,最常见的是视觉(24%,其中 21%仅为轻度),其次是嗅觉(6%)、触觉(4%)、听觉(2%)和味觉(1%)。eSAPS-PD 检测到的精神病症状患者多于所有其他评估(临床访视、UPDRS 第 1 部分和 NMS-Quest)(n=22,11%)的总和(n=55,28%)。与 PD-对照相比,PDP-轻度患者的非运动症状量表(Non-Motor Symptoms Scale)上的其他非运动症状负担更高(37[27-51] vs. 18[9-36],p<0.001),帕金森病生活质量问卷(PD Quality of Life Questionnaire)上的生活质量评分更低(138[125-151] vs. 149[137-165],p=0.01)。
eSAPS-PD 可显著提高 PD 中精神病症状的检出率。